Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SDHC pseudogene 3 (SDHCP3) is a pseudogene related to the *SDHC* gene, which encodes a subunit of succinate dehydrogenase (mitochondrial complex II). *SDHCP3* is a non-coding, non-functional segment of DNA that shares sequence similarity with the protein-coding SDHC gene, but does not produce a functional protein. While several pseudogenes for SDHC exist on different chromosomes[1][5], there is no evidence that SDHCP3 has clinical significance, biological function, or relevance as a therapeutic target. It is not associated with any diseases, biological pathways, or drug interactions and is not considered a receptor, enzyme, transporter, or other canonical drug target. There are multiple SDHC-related pseudogenes, but none serve as functional targets. Only the protein-coding gene SDHC (succinate dehydrogenase complex subunit C) is relevant for mitochondrial metabolism, tumor suppression, and diseases such as paraganglioma and gastrointestinal stromal tumor[1][3][4][5][7]. SDHCP3 is distinct from the actual SDHC gene and is not therapeutically actionable. If you seek data on SDHC as a target, focus on the canonical protein-coding gene, not its pseudogenes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SDHC pseudogene 3 (SDHCP3).